(firstQuint)A Clinical Evaluation of a Novel Multi-Wavelength Laser for Benign Pigmented Lesion Removal.

 The purpose of this investigation is to evaluate the safety and efficacy of an investigational version of the Cutera enlightenTM laser for benign pigmented lesion (BPL) removal.

 Currently, the enlightenTM laser offers two wavelengths: 532nm KTP and 1064nm Nd:YAG.

 The version of the laser under investigation allows the user to choose from a range of wavelengths.

.

 A Clinical Evaluation of a Novel Multi-Wavelength Laser for Benign Pigmented Lesion Removal@highlight

To evaluate the safety and efficacy of an investigational version of the Cutera enlightenTM laser that offers multiple wavelengths for removal of benign pigmented lesions.

